
Overview
Background
I am an academic and consultant working in global health with a focus on health technology assessment (HTA), health systems and services research, and the use of medicines in populations. I have a particular interest in the use of data and research for evidence-informed decision making and implementation science in the context of low and middle income countries, especially in sub-Saharan Africa. I have worked on international health projects in Indonesia and am currently working on several projects in HTA and medicines use in Ghana and sub-Saharan Africa. I work with an extensive network of clinicians and health professionals to investigate the use of medicines and adverse effects in general practice, cancer, psychiatry, neurology, and internal medicine. I have honorary or visiting appointments at the University of Queensland (UQ, Brisbane, Australia), Imperial College London (UK, International Decision Support Initiative) and Kwame Nkrumah University of Science and Technology (KNUST, Kumasi, Ghana). I have a BSc(Hons) and MPH from UQ and a PhD from Monash University. I have lived or worked in Australia (Brisbane, Melbourne), Canada (Toronto), Indonesia (Yogyakarta), UK (London), and Ghana (Accra, Kumasi). I worked as a consultant in HTA in Australia for many years evaluating submissions to subsidise medicines on the Pharmaceutical Benefits Scheme (PBS). I am an experienced teacher having coordinated courses, lectured, and tutored in undergraduate and postgraduate programs. I was a Foundation Coordinator in the UQ Master of Pharmaceutical Industry Practice (from 2019). I am an advisor on diverse PhD and student research projects.
Availability
- Dr Sam Hollingworth is:
- Not available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor (Honours) of Science (Advanced), The University of Queensland
- Doctor of Philosophy, Monash University
- Masters (Coursework) of Public Health, The University of Queensland
Research interests
-
Health technology assessment (HTA) and decision-making
Working with partners in low and middle income countries to manage and allocate their finite resources to ensure their healthcare systems meet the need for universal healthcare coverage efficiently and equitably
-
Economic evaluations within health care and evidence-based practice
Critically appraising the quality of evidence and ‘value for money’ of medicines and health services
-
Use of medicines in populations (pharmacoepidemiology)
Exploring the use of medicines and their side effects using routinely collected data and describing the ‘real world’ effectiveness of medicines (e.g. in cancer)
-
Health systems, services, and medicines in non-communicable diseases
Describing the use of medicines and other health services to treat non-communicable diseases (NCDs) with a focus on low and middle income countries
Works
Search Professor Sam Hollingworth’s works on UQ eSpace
2016
Journal Article
Pharmacy workforce to prevent and manage non-communicable diseases in developing nations
Khanal, Saval, Nissen, Lisa, Veerman, Lennert and Hollingworth, Samantha (2016). Pharmacy workforce to prevent and manage non-communicable diseases in developing nations. Research in Social and Administrative Pharmacy, 12 (4), 655-659. doi: 10.1016/j.sapharm.2015.09.005
2016
Journal Article
Knowledge and attitudes of final year pharmacy students toward opioid substitution therapy
Snoswell, Centaine L. and Hollingworth, Samantha A. (2016). Knowledge and attitudes of final year pharmacy students toward opioid substitution therapy. Journal of Pharmacy Practice and Research, 46 (3), 216-221. doi: 10.1002/jppr.1202
2016
Journal Article
Associations of guideline recommended medications for acute coronary syndromes with fall-related hospitalizations and cardiovascular events in older women with ischemic heart disease
Peeters, Geeske, Tett, Susan E., Hollingworth, Samantha A., Gnjidic, Danijela, Hilmer, Sarah N., Dobson, Annette J. and Hubbard, Ruth E. (2016). Associations of guideline recommended medications for acute coronary syndromes with fall-related hospitalizations and cardiovascular events in older women with ischemic heart disease. Journals of Gerontology - Series A: Biological Sciences and Medical Sciences, 72 (2), 259-265. doi: 10.1093/gerona/glw111
2016
Journal Article
Understanding quality use of medicines in refugee communities in Australian primary care: a qualitative study
Kay, Margaret, Wijayanayaka, Shanika, Cook, Harriet and Hollingworth, Samantha (2016). Understanding quality use of medicines in refugee communities in Australian primary care: a qualitative study. British Journal of General Practice, 66 (647), E397-E409. doi: 10.3399/bjgp16X685249
2016
Journal Article
Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes
Mayfield, Karla, Siskind, Dan, Winckel, Karl, Russell, Anthony W., Kisely, Steve, Smith, Greg and Hollingworth, Samantha (2016). Glucagon-like peptide-1 agonists combating clozapine-associated obesity and diabetes. Journal of Psychopharmacology, 30 (3), 227-236. doi: 10.1177/0269881115625496
2016
Conference Publication
Using de-identified dispensing data to identify possible medication misuse and facilitate cross-national comparison
Kairuz, Therese, Truter, Ilse, Pudmenzky, Alex, Fredericks, Ian, Rossato, Laurence and Hollingworth, Samantha (2016). Using de-identified dispensing data to identify possible medication misuse and facilitate cross-national comparison. 2nd Medicines Utilisation Research in Africa Symposium, Gaborone, Botswana, 25-27 July 2016.
2016
Conference Publication
Use and Costs of Disease-Modifying Anti-Rheumatic Drugs and Biologic Dmards in Australia Between 2004 and 2014
Ellen, Donges, Christine, Staatz, Paul, Kubler, Helen, Benham and Samantha, Hollingworth (2016). Use and Costs of Disease-Modifying Anti-Rheumatic Drugs and Biologic Dmards in Australia Between 2004 and 2014. *, *, *. HOBOKEN: WILEY-BLACKWELL.
2016
Journal Article
A review of medication use as an indicator of human health impact in environmentally stressed areas
Hollingworth, Samantha A., Kim, Diane Dabok and Jagals, Paul (2016). A review of medication use as an indicator of human health impact in environmentally stressed areas. Annals of Global Health, 82 (1), 111-118. doi: 10.1016/j.aogh.2016.01.010
2016
Conference Publication
Does consumer medicines interest reflect medicines use?
McGuire, T. M., Pache, D. M., van Driel, M. L. and Hollingworth, S. A. (2016). Does consumer medicines interest reflect medicines use?. Annual Conference of Australasian Pharmaceutical Science Association, Sydney University, Sydney, NSW, 2-5 December 2016.
2016
Conference Publication
Erlotinib Survival and Use in Nonsmall Cell Lung Cancer At Two Large Queensland Public Hospitals: Comparison to Pivotal Trials Supporting Subsidy On the Pharmaceutical Benefits Scheme
McGrath, Alexandria, Sandhu, Geeta, McCaffrey, Elizabeth, Walpole, Euan, McKavanagh, Daniel and Hollingworth, Samantha (2016). Erlotinib Survival and Use in Nonsmall Cell Lung Cancer At Two Large Queensland Public Hospitals: Comparison to Pivotal Trials Supporting Subsidy On the Pharmaceutical Benefits Scheme. COSA's 43rd and ANZBCTG's 38th Annual Scientific Meetings. Partners for Progress in Breast Cancer Research and Care, Gold Coast, QLD Australia, 15–17 November 2016. United Kingdom: Wiley-Blackwell . doi: 10.1111/ajco.12646
2015
Journal Article
Consumer knowledge and perceptions about antibiotics and upper respiratory tract infections in a community pharmacy
Fredericks, Ian, Hollingworth, Samantha, Pudmenzky, Alex, Rossato, Laurence, Syed, Shahzad and Kairuz, Therese (2015). Consumer knowledge and perceptions about antibiotics and upper respiratory tract infections in a community pharmacy. International Journal of Clinical Pharmacy, 37 (6), 1213-1221. doi: 10.1007/s11096-015-0188-y
2015
Conference Publication
Lenalidomide use in relapsed or refractory multiple myeloma patients at five large Queensland public hospitals
McKavanagh, Daniel, Walpole, Euan, Hollingworth, Samantha, Sharkey, Megan and Mollee, Peter (2015). Lenalidomide use in relapsed or refractory multiple myeloma patients at five large Queensland public hospitals. COSA’s 42nd Annual Scientific Meeting. Rare Cancers: Common Goals, Hobart, TAS, Australia, 17–19 November 2015. Chichester, West Sussex, United Kingdom: Wiley-Blackwell.
2015
Journal Article
Dopamine agonists: time pattern of adverse effects reporting in Australia
Hollingworth, Samantha A., McGuire, Treasure M., Pache, David and Eadie, Mervyn J. (2015). Dopamine agonists: time pattern of adverse effects reporting in Australia. Drugs - Real World Outcomes, 2 (3), 199-203. doi: 10.1007/s40801-015-0028-3
2015
Journal Article
Opioid analgesic prescribing in Australia: a focus on gender and age
Hollingworth, Samantha A., Gray, Paul D., Hall, Wayne D. and Najman, Jake M. (2015). Opioid analgesic prescribing in Australia: a focus on gender and age. Pharmacoepidemiology and Drug Safety, 24 (6), 628-636. doi: 10.1002/pds.3767
2015
Journal Article
Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013
Forrester, T., Siskind, D., Winckel, K., Wheeler, A. and Hollingworth, S. (2015). Increasing Clozapine Dispensing Trends in Queensland, Australia 2004–2013. Pharmacopsychiatry, 48 (4-5), 164-169. doi: 10.1055/s-0035-1554713
2015
Journal Article
Clozapine-induced myocarditis: separating the wheat from the chaff
Winckel, Karl, Siskind, Dan, Hollingworth, Samantha and Wheeler, Amanda (2015). Clozapine-induced myocarditis: separating the wheat from the chaff. Australian and New Zealand Journal of Psychiatry, 49 (2), 188-188. doi: 10.1177/0004867414554269
2015
Journal Article
Shift in disease burden from communicable to non-communicable diseases: aiming to achieve Universal Health Coverage in Nepal
Khanal, Saval, Veerman, Lennert, Hollingworth, Samantha and Nissen, Lisa (2015). Shift in disease burden from communicable to non-communicable diseases: aiming to achieve Universal Health Coverage in Nepal. Perspective in Public Health, 135 (4), 177-178. doi: 10.1177/1757913915586654
2015
Conference Publication
Trends in the use and costs of disease-modifying anti-rheumatic drugs (DMARD) in Australia.
Donges, E., Staatz, C. E. and Hollingworth, S. A. (2015). Trends in the use and costs of disease-modifying anti-rheumatic drugs (DMARD) in Australia.. APSA-ASCEPT conference, Hobart, Australia, 29th November - 2nd December 2015.
2015
Journal Article
Clozapine in the community: improved access or risky free- for-all
Winckel, Karl, Siskind, Dan, Hollingworth, Sam, Robinson, Gail, Mitchell, Scott, Varghese, Daniel, Smith, Lesley and Wheeler, Amanda (2015). Clozapine in the community: improved access or risky free- for-all. Australian and New Zealand Journal of Psychiatry, 49 (10), 863-865. doi: 10.1177/0004867415592957
2015
Journal Article
Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial
Mayfield, Karla, Siskind, Dan, Winckel, Karl, Hollingworth, Samantha, Kisely, Steve and Russell, Anthony W. (2015). Treatment of clozapine-associated obesity and diabetes with exenatide (CODEX) in adults with schizophrenia: study protocol for a pilot randomised controlled trial. BJPsych Open, 1 (1), 67-73. doi: 10.1192/bjpo.bp.115.001073
Funding
Past funding
Supervision
Availability
- Dr Sam Hollingworth is:
- Not available for supervision
Supervision history
Current supervision
-
Doctor Philosophy
Dynamics of patient-based benefit-risk assessment and information seeking for medication decision-making in chronic disease
Principal Advisor
Other advisors: Dr Treasure McGuire, Associate Professor Helen Benham
-
Doctor Philosophy
Addressing early discontinuation of antidepressant treatment from a patient and health care professional perspective
Associate Advisor
Other advisors: Associate Professor Maria Donald, Dr Treasure McGuire
-
Doctor Philosophy
Addressing early discontinuation of antidepressant treatment from a patient and health care professional perspective
Associate Advisor
Other advisors: Associate Professor Maria Donald, Dr Treasure McGuire
Completed supervision
-
2019
Doctor Philosophy
Evolving management of menopausal symptoms in Australian women: Response to evidence changes about hormone therapy
Principal Advisor
Other advisors: Dr Treasure McGuire
-
2016
Doctor Philosophy
Medicine access issues and pharmacist-delivered services in the management of non-communicable diseases in low and middle-income countries: the case of Nepal
Principal Advisor
Other advisors: Professor Lisa Nissen
-
2023
Doctor Philosophy
Small is Beautiful: Knowledge Sharing Dynamics in Indonesia's Puskesmas Model of Primary Health Care
Associate Advisor
Other advisors: Dr Alastair Stark, Associate Professor Ryan Walter
-
2020
Doctor Philosophy
Prescription opioids dispensing: trends and risk of unintentional overdose
Associate Advisor
Other advisors: Dr Joemer Maravilla, Professor Jason Connor
-
2016
Master Philosophy
Factors Affecting Appropriate Use of Antibiotics: A Pilot Study in Community Pharmacy
Associate Advisor
-
2013
Doctor Philosophy
Healthcare access, medicine access and medicine regulation in nine developing and developed countries: a qualitative investigation of pharmacists' perspectives
Associate Advisor
Other advisors: Associate Professor Kathryn Steadman, Professor Lisa Nissen
Media
Enquiries
Contact Dr Sam Hollingworth directly for media enquiries about:
- health services research
- medicine use in populations
- pharmacoepidemiology
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: